Neurostimulation devices consider the implantable and non-implantable neurostimulation devices which act on the spinal cord and brain to deliver the electrical stimulation to a targeted area.

1. Global
Neurostimulation
Devices Market
Analysis and Forecast: 2021-2030
August 2020
TOC

2. Global Neurostimulation Devices Market
All rights reserved at BIS Research 2
BIS Research is a leading market intelligence and technology research company. BIS Research
publishes in-depth market intelligence reports focusing on the market estimations, technology
analysis, emerging high-growth applications, deeply segmented granular country-level market data,
and other important market parameters useful in the strategic decision making for senior
management. BIS Research provides multi-client reports, company profiles, databases, and custom
research services.
Copyright © 2020 BIS Research
All Rights Reserved. This document contains highly confidential information and is the sole property
of BIS Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all
contents of this document is strictly prohibited. Access to this information is provided exclusively for
the benefit of the people or organization concerned. It may not be accessed by or offered whether for
sale or otherwise to any third party.

3. Global Neurostimulation Devices Market
All rights reserved at BIS Research 3
Table of Contents
Executive Summary……………………………………………...…………….25
1. Product Definition ..................................................................................................36
2. Research Scope......................................................................................................37
2.1 Scope of Study..............................................................................................37
2.2 Inclusion and Exclusion Criteria of the Report ..........................................39
2.2.1 Inclusion Criteria ............................................................................39
2.2.2 Exclusion Criteria of the Report....................................................39
2.3 Key Questions Answered in the Report......................................................40
3. Report Methodology...............................................................................................41
3.1 Primary Data Sources...................................................................................42
3.2 Secondary Data Sources..............................................................................43
3.3 Data Sources Categorization .......................................................................44
3.4 Selection Criteria for Company Profiles......................................................45
3.5 Assumptions and Limitations......................................................................46
4. Competitive Landscape .........................................................................................47
4.1 Key Developments and Strategies ..............................................................47
4.1.1 Regulatory and Legal Landscape .................................................49
4.1.2 Funding Activities and Investments .............................................50
4.1.3 Partnerships, Collaborations, Alliances, and Business
Expansions .....................................................................................51
4.1.4 New Offerings .................................................................................52
4.1.5 Mergers and Acquisition Activities...............................................53
4.2 Market Share Analysis..................................................................................54
4.2.1 Market Share Analysis (by Company) ..........................................54
4.2.2 Market Share Analysis for Global Spinal Cord Stimulation
Devices Market, 2019 .....................................................................55

4. Global Neurostimulation Devices Market
All rights reserved at BIS Research 4
4.2.3 Market Share Analysis for Global Deep Brain Stimulation
Devices Market, 2019 .....................................................................57
4.2.4 Market Share Analysis for Global Auditory Brainstem
Implant Market, 2019 ......................................................................58
4.3 Product Analysis...........................................................................................59
4.4 Growth Share Analysis.................................................................................61
5. Impact of COVID-19 on Neurostimulation Devices Market .................................63
5.1 Impact on Global Treatment Landscape .....................................................63
5.2 Impact on Adoption Rate of Neurostimulation Devices.............................64
5.3 Impact on Global Market Size ......................................................................65
5.4 Entry Barriers and Opportunities for the Companies in Global
Neurostimulation Devices Market................................................................66
6. Industry Analysis....................................................................................................68
6.1 Regulatory Framework .................................................................................68
6.1.1 Regulations in North America .......................................................68
6.1.1.1 U.S..............................................................................................68
6.1.1.2 Canada .......................................................................................69
6.1.2 Regulations in Europe ...................................................................70
6.1.3 Regulations in Asia-Pacific ...........................................................70
6.1.3.1 National Medical Products Administration (NMPA) .....................71
6.1.3.2 Pharmaceutical and Medical Device Agency (PMDA).................71
6.1.3.3 Therapeutic Goods Administration (TGA) ...................................72
6.2 Societies, Consortium, and Associations for Global Neurostimulation
Devices Market..............................................................................................73
6.3 Patent Analysis .............................................................................................74
6.4 Product Pipeline............................................................................................75
7. Global Neurostimulation Devices Market.............................................................77
7.1 Market Overview............................................................................................77
7.2 Evolution of the Neurostimulation Therapy................................................77
7.3 Global Market Scenario ................................................................................78
7.4 Assumptions and Limitations......................................................................79

5. Global Neurostimulation Devices Market
All rights reserved at BIS Research 5
7.5 Market Dynamics...........................................................................................81
7.6 Impact Analysis.............................................................................................82
7.6.1 Market Drivers ................................................................................83
7.6.1.1 Growing Incidence of Neurological Disorders .............................83
7.6.1.2 Increased Side-Effects of Pain Management Medications in
Geriatric Population ....................................................................85
7.6.1.3 Limited Success Rate of Drugs Targeting Specific Disease .......85
7.6.1.4 Advent of Sedentary Lifestyles Resulting in Massive
Burden of Chronic Pain...............................................................86
7.6.1.5 Growing Concerns Pertaining to Pelvic Health of Geriatric
Population...................................................................................87
7.6.2 Market Restraints ...........................................................................87
7.6.2.1 Financial Burden of Product Recalls ...........................................87
7.6.2.2 Increased Regulatory Scrutiny ....................................................90
7.6.2.3 High Cost of Equipment ..............................................................90
7.6.3 Market Opportunities .....................................................................91
7.6.3.1 Evolution of Biomarker-Based Therapeutics Enabling Early
Diagnostics of Neurological Disorders ........................................91
7.6.3.2 Development of Closed Loop Neuromodulation..........................92
8. Global Neurostimulation Devices (by Product Type) ..........................................93
8.1 Implantable Neurostimulation Devices .......................................................94
8.1.1 Spinal Cord Stimulation Devices ..................................................96
8.1.1.1 Rechargeable Spinal Cord Stimulation .......................................99
8.1.1.2 Non-Rechargeable Spinal Cord Stimulation..............................100
8.1.2 Auditory Brainstem Implant ........................................................101
8.1.3 Deep Brain Stimulation (DBS) .....................................................103
8.1.3.1 Single Channel DBS .................................................................104
8.1.3.2 Dual Channel DBS....................................................................105
8.1.4 Vagus Nerve Stimulation (VNS) Devices....................................106
8.1.5 Sacral Nerve Stimulation (SNS) Devices....................................108
8.1.6 Hypoglossal Nerve Stimulation Devices ....................................109
8.1.7 Others Implantable Neurostimulation Devices ..........................110

6. Global Neurostimulation Devices Market
All rights reserved at BIS Research 6
8.2 Non-Implantable Neurostimulation Devices .............................................112
8.2.1 Transcranial Magnetic Stimulation (TMS) ..................................114
8.2.2 Others Non-Implantable Neurostimulation Device....................115
9. Global Neurostimulation Devices Market (by Application)...............................116
9.1 Pain Management........................................................................................118
9.2 Hearing Loss ...............................................................................................119
9.3 Parkinson’s Disease ...................................................................................120
9.4 Epilepsy .......................................................................................................121
9.5 Urinary and Fecal Incontinence.................................................................122
9.6 Depression...................................................................................................124
9.7 Other Applications......................................................................................125
10. Global Neurostimulation Devices Market (by Region) ......................................127
10.1 North America .............................................................................................128
10.1.1 North America Neurostimulation Devices Market
(by Product Type).........................................................................131
10.1.1.1 North America Implantable Neurostimulation Devices Market
(by Type)...................................................................................132
10.1.2 North America Neurostimulation Devices Market
(by Country)..................................................................................133
10.1.2.1 U.S............................................................................................134
10.1.2.2 Canada .....................................................................................136
10.2 Europe..........................................................................................................138
10.2.1 Europe Neurostimulation Devices Market (by Product Type) ..142
10.2.1.1 Europe Implantable Neurostimulation Devices Market
(by Type)...................................................................................143
10.2.2 Europe Neurostimulation Devices Market (by Country) ...........144
10.2.2.1 Germany ...................................................................................145
10.2.2.2 U.K............................................................................................146
10.2.2.3 France.......................................................................................148
10.2.2.4 Italy ...........................................................................................150
10.2.2.5 Spain.........................................................................................152
10.2.2.6 Russia.......................................................................................153

7. Global Neurostimulation Devices Market
All rights reserved at BIS Research 7
10.2.2.7 Switzerland ...............................................................................155
10.2.2.8 Rest-of-Europe..........................................................................156
10.3 Asia-Pacific..................................................................................................157
10.3.1 Asia-Pacific Neurostimulation Devices Market
(by Product Type).........................................................................160
10.3.1.1 Asia-Pacific Implantable Neurostimulation Devices Market
(by Type)...................................................................................161
10.3.2 Asia-Pacific Neurostimulation Devices Market (by Country) ...162
10.3.2.1 Japan ........................................................................................163
10.3.2.2 China.........................................................................................164
10.3.2.3 India ..........................................................................................166
10.3.2.4 Australia....................................................................................168
10.3.2.5 South Korea ..............................................................................170
10.3.2.6 Rest-of-Asia-Pacific...................................................................171
10.4 Latin America ..............................................................................................172
10.4.1 Latin America Neurostimulation Devices Market
(by Product Type).........................................................................175
10.4.1.1 Latin America Implantable Neurostimulation Devices Market
(by Type)...................................................................................176
10.4.2 Latin America Neurostimulation Devices Market
(by Country)..................................................................................177
10.4.2.1 Brazil.........................................................................................178
10.4.2.2 Mexico.......................................................................................179
10.4.2.3 Argentina...................................................................................181
10.4.2.4 Rest-of-Latin America ...............................................................182
10.4.3 Middle East and Africa (MEA)......................................................183
10.4.4 Middle East and Africa Neurostimulation Devices Market
(by Product Type).........................................................................186
10.4.5 Middle East and Africa Implantable Neurostimulation
Devices Market (by Type) ............................................................187
11. Company Profiles.................................................................................................188
11.1 Abbott Laboratories....................................................................................188
11.1.1 Company Overview ......................................................................188

8. Global Neurostimulation Devices Market
All rights reserved at BIS Research 8
11.1.2 Role of Abbott Laboratories in the Neurostimulation
Device Market ...............................................................................188
11.1.3 Financials......................................................................................190
11.1.4 SWOT Analysis.............................................................................194
11.2 Axonics Modulation Technologies, Inc.....................................................195
11.2.1 Company Overview ......................................................................195
11.2.2 Role of Axonics Modulation Technologies, Inc. in the
Neurostimulation Devices Market...............................................195
11.2.3 Financials......................................................................................197
11.2.4 SWOT Analysis.............................................................................198
11.3 Beijing PINS Medical Co., Ltd. ...................................................................199
11.3.1 Company Overview ......................................................................199
11.3.2 Role of Beijing PINS Medical Co., Ltd. in the
Neurostimulation Devices Market...............................................199
11.3.3 SWOT Analysis.............................................................................201
11.4 Boston Scientific Corporation ...................................................................202
11.4.1 Company Overview ......................................................................202
11.4.2 Role of Boston Scientific Corporation in the
Neurostimulation Devices Market...............................................202
11.4.3 Financials......................................................................................204
11.4.4 SWOT Analysis.............................................................................208
11.5 Cochlear Ltd. ...............................................................................................209
11.5.1 Company Overview ......................................................................209
11.5.2 Role of Cochlear Ltd. in the Neurostimulation Devices
Market............................................................................................209
11.5.3 Financials......................................................................................211
11.5.4 SWOT Analysis.............................................................................214
11.6 electroCore, Inc...........................................................................................215
11.6.1 Company Overview ......................................................................215
11.6.2 Role of electroCore, Inc. in the Neurostimulation Devices
Market............................................................................................215
11.6.3 Financials......................................................................................216
11.6.4 SWOT Analysis.............................................................................218

9. Global Neurostimulation Devices Market
All rights reserved at BIS Research 9
11.7 Helius Medical Technologies, Inc. .............................................................219
11.7.1 Company Overview ......................................................................219
11.7.2 Helius Medical Technologies, Inc. in the Neurostimulation
Devices Market .............................................................................219
11.7.3 Financials......................................................................................221
11.7.4 SWOT Analysis.............................................................................222
11.8 Inspire Medical Systems, Inc. ....................................................................223
11.8.1 Company Overview ......................................................................223
11.8.2 Role of Inspire Medical System, Inc. in the Neurostimulation
Devices Market .............................................................................223
11.8.3 Financials......................................................................................225
11.8.4 SWOT Analysis.............................................................................227
11.9 Laborie Medical Technologies, Inc............................................................228
11.9.1 Company Overview ......................................................................228
11.9.2 Role of Laborie Medical Technologies, Inc. in the
Neurostimulation Devices Market...............................................228
11.9.3 SWOT Analysis.............................................................................229
11.10LivaNova PLC..............................................................................................230
11.10.1 Company Overview ......................................................................230
11.10.2 Role of LivaNova PLC in the Neurostimulation Devices
Market............................................................................................230
11.10.3 Financials......................................................................................232
11.10.4 SWOT Analysis.............................................................................235
11.11MED-EL ........................................................................................................236
11.11.1 Company Overview ......................................................................236
11.11.2 Role of MED-EL in the Neurostimulation Devices Market.........236
11.11.3 SWOT Analysis.............................................................................237
11.12Medtronic Plc...............................................................................................238
11.12.1 Company Overview ......................................................................238
11.12.2 Role of Medtronic plc in the Neurostimulation Devices
Market............................................................................................238
11.12.3 Financials......................................................................................240
11.12.4 SWOT Analysis.............................................................................243

10. Global Neurostimulation Devices Market
All rights reserved at BIS Research 10
11.13NeuroMetrix, Inc..........................................................................................244
11.13.1 Company Overview ......................................................................244
11.13.2 Role of NeuroMetrix, Inc. in the Neurostimulation Devices
Market............................................................................................244
11.13.3 Financials......................................................................................246
11.13.4 SWOT Analysis.............................................................................247
11.14NeuroPace, Inc. ...........................................................................................248
11.14.1 Company Overview ......................................................................248
11.14.2 Role of NeuroPace, Inc. in the Neurostimulation Devices
Market............................................................................................248
11.14.3 SWOT Analysis.............................................................................249
11.15Nevro Corporation ......................................................................................250
11.15.1 Company Overview ......................................................................250
11.15.2 Role of Nevro Corporation in the Neurostimulation Devices
Market............................................................................................250
11.15.3 Financials......................................................................................251
11.15.4 SWOT Analysis.............................................................................253
11.16Sonova .........................................................................................................254
11.16.1 Company Overview ......................................................................254
11.16.2 Role of Sonova in the Neurostimulation Devices Market .........254
11.16.3 Financials......................................................................................255
11.16.4 SWOT Analysis.............................................................................258
11.17Synapse Biomedical Inc. ............................................................................259
11.17.1 Company Overview ......................................................................259
11.17.2 Role of Synapse Biomedical Inc. in the Neurostimulation
Devices Market .............................................................................259
11.17.3 SWOT Analysis.............................................................................261
11.18The Magstim Company Limited .................................................................262
11.18.1 Company Overview ......................................................................262
11.18.2 Role of The Magstim Company Limited in the
Neurostimulation Devices Market...............................................262
11.18.3 SWOT Analysis.............................................................................263

11. Global Neurostimulation Devices Market
All rights reserved at BIS Research 11
List of Tables
Table 1: Mortality Due to Opioid-Use Disorders.................................................................................. 26
Table 4.1: Product Analysis of Neurostimulation Devices .................................................................. 60
Table 5.1: Impact of COVID-19 on Treatment Landscape ................................................................. 63
Table 6.1: Global Neurostimulation Devices Market (Association/Consortium/Society) ................... 73
Table 6.2: Product Pipeline Analysis of Neurostimulation Devices.................................................... 76
Table 7.1: Some of the Recalled Neurostimulation Devices .............................................................. 88
Table 8.1: Specification of Different Spinal Cord Stimulation Device Offered by Different
Companies...................................................................................................................... 98
Table 10.1: Prevalence of Neurological Diseases in North America, 2014-2017............................ 129
Table 10.2: Prevalence of Neurological Diseases in the U.S., 2014-2017 ...................................... 135
Table 10.3: Prevalence of Neurological Diseases in Canada, 2014-2017....................................... 137
Table 10.4: Prevalence of Neurological Diseases in Europe, 2014-2017........................................ 139
Table 10.5: Prevalence of Neurological Diseases in Germany, 2014-2017 .................................... 145
Table 10.6: Prevalence of Neurological Diseases in the U.K., 2014-2017 ...................................... 147
Table 10.7: Prevalence of Neurological Diseases in France, 2014-2017........................................ 149
Table 10.8: Prevalence of Neurological Diseases in Italy, 2014-2017............................................. 151
Table 10.9: Prevalence of Neurological Diseases in Spain, 2014-2017 .......................................... 152
Table 10.10: Prevalence of Neurological Diseases in Russia, 2014-2017 ...................................... 154
Table 10.11: Prevalence of Neurological Diseases in Switzerland, 2014-2017 .............................. 155
Table 10.12: Prevalence of Neurological Diseases in Asia-Pacific, 2014-2017 .............................. 158
Table 10.13: Prevalence of Neurological Diseases in Japan, 2014-2017 ....................................... 163
Table 10.14: Prevalence of Neurological Diseases in China, 2014-2017........................................ 165
Table 10.15: Prevalence of Neurological Diseases in India, 2014-2017.......................................... 167
Table 10.16: Prevalence of Neurological Diseases in Australia, 2014-2017 ................................... 169
Table 10.17: Prevalence of Neurological Diseases in South Korea, 2014-2017............................. 170
Table 10.18: Prevalence of Neurological Diseases in Latin America, 2014-2017........................... 173

12. Global Neurostimulation Devices Market
All rights reserved at BIS Research 12
Table 10.19: Prevalence of Neurological Diseases in Brazil, 2014-2017 ........................................ 178
Table 10.20: Prevalence of Neurological Diseases in Mexico, 2014-2017...................................... 180
Table 10.21: Prevalence of Neurological Diseases in Argentina, 2014-2017.................................. 181

13. Global Neurostimulation Devices Market
All rights reserved at BIS Research 13
List of Figures
Figure 1: Percentage Share of Neurological Disorders Causing Global Deaths
(2005, 2015, and 2030) .................................................................................................. 24
Figure 2: Global Neurostimulation Devices Market, 2019-2030......................................................... 27
Figure 3: Growth Promoting and Growth Inhibiting Factors of Global Neurostimulation Devices
Market.............................................................................................................................. 28
Figure 4: Global Neurostimulation Devices Market: Patent Analysis (by Year of Filing), January
2016-May 2020............................................................................................................... 29
Figure 5: Share of Key Developments and Strategies, January 2016-May 2020.............................. 30
Figure 6: Market Share Analysis for the Global Neurostimulation Devices Market (by Company),
2019................................................................................................................................. 30
Figure 7: Global Neurostimulation Devices Market (by Product Type), 2019-2030 .......................... 32
Figure 8: Global Neurostimulation Devices Market (by Application), 2019 and 2030 ....................... 33
Figure 9: Global Neurostimulation Devices Market (by Region), 2019 and 2030.............................. 34
Figure 2.1: Global Neurostimulation Devices Market Segmentation.................................................. 38
Figure 3.1: Global Neurostimulation Devices Market Research Methodology .................................. 41
Figure 3.2: Primary Research.............................................................................................................. 43
Figure 3.3: Secondary Research......................................................................................................... 43
Figure 3.4: Shares of Key Company Profiles ...................................................................................... 45
Figure 3.5: Assumptions and Limitations............................................................................................. 46
Figure 4.1: Share of Key Developments and Strategies (January 2016-May 2020)......................... 48
Figure 4.2: Regulatory and Legal (by Company), January 2016-May 2020...................................... 49
Figure 4.3: Funding Activities and Investments (by Company), January 2016-May 2020................ 50
Figure 4.4: Partnerships, Alliances, Collaboration, and Business Expansions (by Company),
January 2016-May 2020................................................................................................. 51
Figure 4.5: New Offerings (by Company), January 2016-May 2020.................................................. 52
Figure 4.6: Merger and Acquisition Activities (by Company), January 2016-May 2020.................... 53

14. Global Neurostimulation Devices Market
All rights reserved at BIS Research 14
Figure 4.7: Market Share Analysis for the Global Neurostimulation Devices Market,
(by Company), 2019 ....................................................................................................... 54
Figure 4.8: Market Share Analysis (by Company) for Global Spinal Cord Stimulation Devices
Market, 2019 ................................................................................................................... 56
Figure 4.9: Market Share Analysis (by Company) for Global Deep Brain Stimulation Devices
Market, 2019 ................................................................................................................... 57
Figure 4.10: Market Share Analysis (by Company) for Global Auditory Brainstem Implant
Market, 2019 ................................................................................................................... 59
Figure 4.11: Growth Share Matrix for Global Neurostimulation Devices Market (by Product),
2019................................................................................................................................. 61
Figure 5.1: COVID-19 Impact on the Global Elective Surgeries......................................................... 65
Figure 5.2: Growth Trend of the Neurostimulation Devices................................................................ 66
Figure 5.3: Global Neurostimulation Devices Market: Challenges and Opportunities....................... 67
Figure 6.1: Global Neurostimulation Devices Market: Patent Analysis (by Year of Filing),
January 2016-May 2020................................................................................................. 75
Figure 7.1: Evolution of Neurostimulation Technologies..................................................................... 78
Figure 7.2: Global Neurostimulation Devices Market, 2019-2030...................................................... 79
Figure 7.3: Market Dynamics............................................................................................................... 81
Figure 7.4: Impact Analysis of Market Drivers and Challenges.......................................................... 82
Figure 7.5: Number and Percentage of DALYs for Different Neurological Disorders, 2015 ............. 83
Figure 7.6: Number and Percentage of DALYs for Different Neurological Disorders, 2030 ............. 84
Figure 8.1: Segmentation of Global Neurostimulation Devices Market (by Product Type) ............... 93
Figure 8.2: Global Neurostimulation Devices Market (by Product Type), 2019-2030 ....................... 93
Figure 8.3: Segmentation of Implantable Neurostimulation Devices Market ..................................... 95
Figure 8.4: Global Implantable Neurostimulation Devices Market, 2019-2030.................................. 95
Figure 8.5: Global Implantable Neurostimulation Devices Market, (by Product Type),
2019-2030....................................................................................................................... 96
Figure 8.6: Mechanism Action of Spinal Cord Stimulation Device ..................................................... 97
Figure 8.7: Global Spinal Cord Stimulation Devices Market, (2019-2030)......................................... 99

15. Global Neurostimulation Devices Market
All rights reserved at BIS Research 15
Figure 8.8: Global Rechargeable Spinal Cord Stimulation (SCS) Devices Market, (2020-2030) .. 100
Figure 8.9: Global Non-Rechargeable Spinal Cord Stimulation Devices Market, (2019-2030) ..... 101
Figure 8.10: Mechanism of Action of Auditory Brainstem Implants.................................................. 102
Figure 8.11: Global Auditory Brainstem Implant Market, (2019-2030)............................................. 102
Figure 8.12: Global Deep Brain Stimulation Devices Market, (2019-2030) ..................................... 104
Figure 8.13: Global Single-Channel Deep Brain Stimulation Devices Market, (2019-2030).......... 105
Figure 8.14: Global Dual-Channel Deep Brain Stimulation Devices Market, (2019-2030) ............. 106
Figure 8.15: Global Vagus Nerve Stimulation Devices Market, (2019-2030) .................................. 107
Figure 8.16: Global Sacral Nerve Stimulation Devices Market, (2019-2030) .................................. 109
Figure 8.17: Global Hypoglossal Nerve Stimulation Devices Market, (2019-2030)......................... 110
Figure 8.18: Others Implantable Neurostimulation Devices Market, (2019-2030)........................... 111
Figure 8.19: Segmentation of Non-Implantable Neurostimulation Devices Market......................... 112
Figure 8.20: Global Non-Implantable Neurostimulation Devices Market, (by Product Type),
2019-2030..................................................................................................................... 113
Figure 8.21: Global Transcranial Magnetic Stimulation (TMS) Devices Market, (2019-2030)....... 114
Figure 8.22: Others Non-Implantable Neurostimulation Devices Market, (2019-2030)................... 115
Figure 9.1: Segmentation of Neurostimulation Devices Market (by Application)............................. 116
Figure 9.2: Global Neurostimulation Devices Market (by Application), 2019-2030 ......................... 117
Figure 9.3: Global Neurostimulation Devices Market (Pain Management), 2019-2030 .................. 119
Figure 9.4: Global Neurostimulation Devices Market (Hearing Loss), 2019-2030........................... 120
Figure 9.5: Global Neurostimulation Devices Market (Parkinson’s Disease), 2019-2030............... 121
Figure 9.6: Global Neurostimulation Devices Market (Epilepsy), 2019-2030 .................................. 122
Figure 9.7: Global Neurostimulation Devices Market (Urinary and Fecal Incontinence),
2019-2030..................................................................................................................... 124
Figure 9.8: Global Neurostimulation Devices Market (Depression), 2019-2030.............................. 125
Figure 9.9: Global Neurostimulation Devices Market (Other Applications), 2019-2030 .................. 126
Figure 10.1: Global Neurostimulation Devices Market (by Region), 2019 and 2030....................... 127
Figure 10.2: North America Neurostimulation Devices Market, 2019-2030..................................... 130
Figure 10.3: North America Neurostimulation Devices Market: Market Dynamics.......................... 130

16. Global Neurostimulation Devices Market
All rights reserved at BIS Research 16
Figure 10.4: North America Neurostimulation Devices Market (by Product Type) 2019-2030 ...... 131
Figure 10.5: North America Implantable Neurostimulation Devices Market (by Type),
2019-2030..................................................................................................................... 132
Figure 10.6: North America Neurostimulation Devices Market (by Country), 2019 and 2030 ....... 133
Figure 10.7: Alzheimer’s Dementia in Different Age Groups in the U.S., 2019 ............................... 134
Figure 10.8: U.S. Neurostimulation Devices Market, 2019-2030 ..................................................... 136
Figure 10.9: Canada Neurostimulation Devices Market, 2019-2030 ............................................... 138
Figure 10.10: Europe Neurostimulation Devices Market, 2019-2030 .............................................. 140
Figure 10.11: Europe Neurostimulation Devices Market: Market Dynamics .................................. 141
Figure 10.12: Europe Neurostimulation Devices Market (by Product Type), 2019-2030................ 142
Figure 10.13: Europe Implantable Neurostimulation Devices Market (by Type), 2019-2030......... 143
Figure 10.14: Europe Neurostimulation Devices Market (by Country), 2019 and 2030.................. 144
Figure 10.15: Germany Neurostimulation Devices Market, 2019-2030........................................... 146
Figure 10.16: U.K. Neurostimulation Devices Market, 2019-2030 ................................................... 148
Figure 10.17: France Neurostimulation Devices Market, 2019-2030............................................... 150
Figure 10.18: Italy Neurostimulation Devices Market, 2019-2030.................................................... 151
Figure 10.19: Spain Neurostimulation Devices Market, 2019-2030................................................. 153
Figure 10.20: Russia Neurostimulation Devices Market, 2019-2030............................................... 154
Figure 10.21: Switzerland Neurostimulation Devices Market, 2019-2030 ....................................... 156
Figure 10.22: Rest-of-Europe Neurostimulation Devices Market, 2019-2030 ................................. 157
Figure 10.23: Asia-Pacific Neurostimulation Devices Market, 2019-2030....................................... 159
Figure 10.24: Asia-Pacific Neurostimulation Devices Market: Market Dynamics ............................ 159
Figure 10.25: Asia-Pacific Neurostimulation Devices Market (by Product Type), 2019-2030........ 160
Figure 10.26: Asia-Pacific Implantable Neurostimulation Devices Market (by Type),
2019-2030..................................................................................................................... 161
Figure 10.27: Asia-Pacific Neurostimulation Devices Market (by Country), 2019 and 2030.......... 162
Figure 10.28: Japan Neurostimulation Devices Market, 2019-2030 ................................................ 164
Figure 10.29: China Neurostimulation Devices Market, 2019-2030................................................. 166
Figure 10.30: India Neurostimulation Devices Market, 2019-2030 .................................................. 168

17. Global Neurostimulation Devices Market
All rights reserved at BIS Research 17
Figure 10.31: Australia Neurostimulation Devices Market, 2019-2030............................................ 169
Figure 10.32: South Korea Neurostimulation Devices Market, 2019-2030...................................... 171
Figure 10.33: Rest-of-Asia-Pacific Neurostimulation Devices Market, 2019-2030.......................... 172
Figure 10.34: Latin America Neurostimulation Devices Market, 2019-2030.................................... 173
Figure 10.35: Latin-America Neurostimulation Devices Market: Market Dynamics......................... 174
Figure 10.36: Latin America Neurostimulation Devices Market (by Product Type), 2019-2030 ..... 175
Figure 10.37: Latin America Implantable Neurostimulation Devices Market (by Type),
2019-2030..................................................................................................................... 176
Figure 10.38: Latin America Neurostimulation Devices Market (by Country), 2019 and 2030 ...... 177
Figure 10.39: Brazil Neurostimulation Devices Market, 2019-2030 ................................................. 179
Figure 10.40: Mexico Neurostimulation Devices Market, 2019-2030............................................... 180
Figure 10.41: Argentina Neurostimulation Devices Market, 2019-2030........................................... 182
Figure 10.42: Rest-of-Latin America Neurostimulation Devices Market, 2019-2030....................... 183
Figure 10.43: Middle East and Africa Neurostimulation Devices Market, 2019-2030 ..................... 184
Figure 10.44: Middle East and Africa Neurostimulation Devices Market: Market Dynamics .......... 185
Figure 10.45: Middle East and Africa Neurostimulation Devices Market (by Product Type)
2019-2030..................................................................................................................... 186
Figure 10.46: Middle East and Africa Implantable Neurostimulation Devices Market (by Type),
2019-2030..................................................................................................................... 187
Figure 11.1: Abbott Laboratories: Overall Product Portfolio ............................................................. 189
Figure 11.2: Abbott Laboratories: Overall Financials, 2017-2019.................................................... 190
Figure 11.3: Abbott Laboratories: Revenue (by Product/Service), 2017-2019................................ 191
Figure 11.4: Abbott Laboratories: Revenue (by Region), 2017-2019 .............................................. 192
Figure 11.5: Abbott Laboratories: R&D Expenditure, 2017-2019..................................................... 193
Figure 11.6: Abbott Laboratories: SWOT Analysis ........................................................................... 194
Figure 11.7: Axonics Modulation Technologies, Inc.: Overall Product Portfolio .............................. 196
Figure 11.8: Axonics Modulation Technologies, Inc.: Overall Financials, 2017-2019 ..................... 197
Figure 11.9: Axonics Modulation Technologies, Inc.: R&D Expenditure, 2017-2019...................... 197
Figure 11.10: Axonics Modulation Technologies, Inc.: SWOT Analysis .......................................... 198

18. Global Neurostimulation Devices Market
All rights reserved at BIS Research 18
Figure 11.11: Beijing PINS Medical Co., Ltd.: Overall Product Portfolio.......................................... 200
Figure 11.12: Beijing PINS Medical Co., Ltd.: SWOT Analysis........................................................ 201
Figure 11.13: Boston Scientific Corporation: Overall Product Portfolio............................................ 203
Figure 11.14: Boston Scientific Corporation: Overall Financials, 2017-2019................................... 204
Figure 11.15: Boston Scientific Corporation: Revenue (by Segment), 2017-2019.......................... 205
Figure 11.16: Boston Scientific Corporation: Revenue (by Sub-segment), 2017-2019................... 205
Figure 11.17: Boston Scientific Corporation: Revenue (by Region), 2017-2019............................. 206
Figure 11.18: Boston Scientific Corporation: R&D Expenditure, 2017-2019 ................................... 207
Figure 11.19: Boston Scientific Corporation: SWOT Analysis.......................................................... 208
Figure 11.20: Cochlear Ltd.: Overall Product Portfolio for Neurostimulation Devices Market......... 210
Figure 11.21: Cochlear Ltd.: Overall Financials, 2017-2019 ............................................................ 211
Figure 11.22: Cochlear Ltd.: Revenue (by Segment), 2017-2019.................................................... 211
Figure 11.23: Cochlear Ltd.: Revenue (by Region), 2017-2019....................................................... 212
Figure 11.24: Cochlear Ltd.: R&D Expenditure................................................................................. 213
Figure 11.25: Cochlear Ltd.: SWOT Analysis.................................................................................... 214
Figure 11.26: electroCore, Inc.: Overall Product Portfolio ................................................................ 215
Figure 11.27: electroCore, Inc.: Overall Financials, 2017-2019 ....................................................... 216
Figure 11.28: electroCore, Inc.: Revenue (by Region), 2017-2019.................................................. 217
Figure 11.29: electroCore, Inc.: R&D Expenditure, 2017-2019........................................................ 217
Figure 11.30: electroCore, Inc.: SWOT Analysis .............................................................................. 218
Figure 11.31: Helius Medical Technologies, Inc.: Overall Product Portfolio .................................... 220
Figure 11.32: Helius Medical Technologies, Inc.: Overall Financials, 2017-2019 ........................... 221
Figure 11.33: Helius Medical Technologies, Inc.: R&D Expenditure, 2017-2019............................ 221
Figure 11.34: Helius Medical Technologies, Inc.: SWOT Analysis .................................................. 222
Figure 11.35: Inspire Medical System, Inc.: Overall Product Portfolio ............................................. 224
Figure 11.36: Inspire Medical System, Inc.: Overall Financials, 2017-2019 .................................... 225
Figure 11.37: Inspire Medical System, Inc.: Revenue (by Region), 2017-2019 .............................. 225
Figure 11.38: Inspire Medical System, Inc.: R&D Expenditure, 2017-2019..................................... 226
Figure 11.39: Inspire Medical System Inc.: SWOT Analysis ............................................................ 227

19. Global Neurostimulation Devices Market
All rights reserved at BIS Research 19
Figure 11.40: Laborie Medical Technologies, Inc.: Overall Product Portfolio .................................. 228
Figure 11.41: Laborie Medical Technologies, Inc.: SWOT Analysis ................................................ 229
Figure 11.42: LivaNova PLC: Overall Product Portfolio.................................................................... 231
Figure 11.43: LivaNova PLC: Overall Financials, 2017-2019........................................................... 232
Figure 11.44: LivaNova PLC (by Segment), 2017-2019................................................................... 232
Figure 11.45: LivaNova PLC: Revenue (by Region), 2017-2019..................................................... 233
Figure 11.46: LivaNova PLC: R&D Expenditure, 2017-2019 ........................................................... 234
Figure 11.47: LivaNova PLC: SWOT Analysis.................................................................................. 235
Figure 11.48: MED-EL: Overall Product Portfolio ............................................................................. 236
Figure 11.49: MED-EL: SWOT Analysis ........................................................................................... 237
Figure 11.50: Medtronic plc: Overall Product Portfolio...................................................................... 239
Figure 11.51: Medtronic Plc: Overall Financials, 2017-2019............................................................ 240
Figure 11.52: Medtronic Plc: Revenue (by Segment), 2017-2019 ................................................... 240
Figure 11.53: Medtronic Plc: Revenue (by Region), 2017-2019 ...................................................... 241
Figure 11.54: Medtronic Plc: Research and Development Expense, 2017-2019............................ 242
Figure 11.55: Medtronic plc: SWOT Analysis.................................................................................... 243
Figure 11.56: NeuroMetrix, Inc.: Overall Product Portfolio ............................................................... 245
Figure 11.57: NeuroMetrix, Inc.: Overall Financials, 2017-2019 ...................................................... 246
Figure 11.58: NeuroMetrix, Inc.: R&D Expenditure, 2017-2019....................................................... 246
Figure 11.59: NeuroMetrix, Inc.: SWOT Analysis ............................................................................. 247
Figure 11.60: NeuroPace, Inc.: Overall Product Portfolio................................................................. 248
Figure 11.61: NeuroPace, Inc.: SWOT Analysis............................................................................... 249
Figure 11.62: Nevro Corporation: Overall Product Portfolio ............................................................. 250
Figure 11.63: Nevro Corporation: Overall Financials, 2017-2019.................................................... 251
Figure 11.64: Nevro Corporation: Revenue (by Region), 2017-2019 .............................................. 252
Figure 11.65: Nevro Corporation: R&D Expenditure, 2017-2019..................................................... 252
Figure 11.66: Nevro Corporation: SWOT Analysis ........................................................................... 253
Figure 11.67: Sonova: Overall Product Portfolio............................................................................... 255
Figure 11.68: Sonova: Overall Financials, 2017-2019...................................................................... 255

20. Global Neurostimulation Devices Market
All rights reserved at BIS Research 20
Figure 11.69: Sonova: Revenue (by Segment), 2017-2019............................................................. 256
Figure 11.70: Sonova: Revenue (by Region), 2017-2019................................................................ 257
Figure 11.71: Sonova: R&D Expenditure, 2017-2019 ...................................................................... 257
Figure 11.72: Sonova: SWOT Analysis............................................................................................. 258
Figure 11.73: Synapse Biomedical Inc.: Overall Product Portfolio................................................... 260
Figure 11.74: Synapse Biomedical Inc.: SWOT Analysis................................................................. 261
Figure 11.75: The Magstim Company Limited: Overall Product Portfolio ........................................ 262
Figure 11.76: The Magstim Company Limited: SWOT Analysis ...................................................... 263

21. Global Neurostimulation Devices Market
All rights reserved at BIS Research 21
BIS Research Offerings:
We are on a mission to harness the potential of disruptive technologies to make businesses thrive in
today’s digital age. We have a vision to be a leading and a preferred knowledge partner for corporates
and institutions worldwide and assist them with market intelligence in the area of emerging
technologies, advisories, and other innovative solutions.
Know More Know More
Know More
Know More

22. Global Neurostimulation Devices Market
All rights reserved at BIS Research 22
Disclaimer
BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in
response to orders. The report is licensed for the customer's internal use only and is subject to
restrictions set henceforth. This document and its contents are confidential and may not be further
distributed, published or reproduced, in whole or in part, by any medium or in any form for any
purpose, without the written consent of BIS Research. The customer will not disclose the contents of
the report, whether directly through any medium or indirectly through incorporation in a database,
marketing list, report or otherwise, or use or permit the use of information to generate any statistical
or other information that is or will be provided to third parties, or voluntarily produce information in
legal proceedings.
Market reports are based on expectations, estimates, and projections as of the date such information
is available. Any recommendation contained in this report may not be suitable for all investors or
businesses. The market conclusions drawn are necessarily based upon a number of estimates and
assumptions that, while considered reasonable by BIS Research as of the date of such statements,
are inherently subject to market fluctuations and business, economic and competitive uncertainties
and contingencies
For more details regarding permission, please contact us:
Email: sales@bisresearch.com
Tel: +1 510 404 8135

23. Global Neurostimulation Devices Market
All rights reserved at BIS Research 23
BIS RESEARCH INC.
39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686
E-mail: info@bisresearch.com | Call Us: +1-510-404-8135
Global Delivery Center
Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,
Sector 126, Noida, U.P., 201303, India
Tel: +91 120 4261540 / 4261544